Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children.
作者信息
Rascher W, Kremens B, Wagner S, Feth F, Hunneman D H, Lang R E
机构信息
University Children's Hospitals, Essen, Germany.
出版信息
J Pediatr. 1993 Jun;122(6):914-6. doi: 10.1016/s0022-3476(09)90018-x.
PMID:8501569
Abstract
Neuropeptide Y (NPY) was studied as a marker for neuroblastoma in 12 children. All but one patient with neuroblastoma had elevated plasma NPY concentrations at diagnosis. During treatment NPY values returned to normal in 9 of 12 children. All three children without normalization of plasma NPY values died; two of them had a relapse and the third died of toxic effects. Plasma NPY appears to be a sensitive marker of neuroblastoma.
摘要
相似文献
1
Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children.
J Pediatr. 1993 Jun;122(6):914-6. doi: 10.1016/s0022-3476(09)90018-x.
2
Neuropeptide Y as a marker in pediatric neuroblastoma.
Pediatr Pathol. 1990;10(1-2):207-16. doi: 10.3109/15513819009067108.
3
Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.神经母细胞瘤患儿血浆神经肽Y与分期、年龄及预后的关系，以及组织神经肽Y
Regul Pept. 1998 Sep 25;75-76:185-90. doi: 10.1016/s0167-0115(98)00067-6.
4
Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Eur J Cancer. 2003 Sep;39(13):1899-903. doi: 10.1016/s0959-8049(03)00376-9.
5
The value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children.
Eur J Pediatr. 1987 Sep;146(5):489-93. doi: 10.1007/BF00441600.
6
Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.
Clin Sci (Lond). 1992 Aug;83(2):205-11. doi: 10.1042/cs0830205.
7
Significance of plasma neuropeptide Y (NPY) in diagnosis and prognosis of neuroblastoma.
Prog Clin Biol Res. 1991;366:359-65.
8
Nervous system-specific enolase in serum as a marker for neuroblastoma.
Pediatrics. 1983 Nov;72(5):696-700.
9
Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.血清香草扁桃酸/高香草酸有助于评估局限性而非转移性神经母细胞瘤患者的预后。
Eur J Cancer. 1992;28A(12):1950-4. doi: 10.1016/0959-8049(92)90234-s.
10
Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
Prog Clin Biol Res. 1991;366:367-73.
引用本文的文献
1
Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance.神经肽 Y 对前列腺癌发生和治疗抵抗的神经旁分泌调节。
Prostate. 2021 Jan;81(1):58-71. doi: 10.1002/pros.24081. Epub 2020 Oct 6.
2
Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.神经肽Y作为神经母细胞瘤的生物标志物和治疗靶点
Am J Pathol. 2016 Nov;186(11):3040-3053. doi: 10.1016/j.ajpath.2016.07.019. Epub 2016 Oct 12.
3
Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.神经肽Y（NPY）在肿瘤生长和进展中的作用：儿科肿瘤学的经验教训
Neuropeptides. 2016 Feb;55:55-66. doi: 10.1016/j.npep.2015.10.005. Epub 2015 Oct 26.
4
Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters.神经肽 Y、网膜素和内脏脂肪组织 visfatin 在人体中的表达：与内分泌和临床参数的关系。
Obes Facts. 2010 Aug;3(4):245-51. doi: 10.1159/000319508. Epub 2010 Aug 3.
Zotero 插件